Monash research in treating anxiety and depression
Pioneered by researchers at Monash University, a promising new, ‘whole person’ approach to the treatment of anxiety and depression has been developed in an effort to improve the effectiveness and efficiency of current treatment, and further improve the lives of those who are living with these, and similar, mental health disorders.
According to national surveys, anxiety and depressive disorders are among the most prevalent mental health diagnoses in Australia, and 60 to 70 per cent of people with anxiety or depression have multiple diagnoses. An estimated 84.3 per cent of individuals with an anxiety or related disorders do seek treatment from a healthcare provider, but only 23.2 per cent receive appropriate evidence-based psychosocial or pharmacological intervention.
While diagnosis-specific cognitive-behavioural therapy (CBT) interventions have generally shown to be effective in treating multiple diagnoses in approximately 40 per cent of cases, the remaining 60 per cent continue to experience one or more clinically severe anxiety, depression, or related diagnoses despite receiving a full course of evidence-based CBT.
Following the discovery of considerable genetic, neurological, developmental, behavioural and cognitive data, which suggested commonalities across anxiety and related disorders, transdiagnostic CBT interventions have been developed to form a new approach to treatment.
This new, transdiagnostic, disorder-independent approach considers the biological, physical and psychological symptoms, targeting the person and their emotional difficulties as a whole to deliver tailored treatment. This, in part, imp